• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PTEN错构瘤综合征患者病理确诊良性病变的深度表型分析

Deep Phenotyping of Pathology-Confirmed Benign Lesions in PTEN Hamartoma Tumor Syndrome Patients.

作者信息

Schei-Andersen Ane J, Schuurs-Hoeijmakers Janneke H M, van der Post Rachel, Mensenkamp Arjen R, Schieving Jolanda, Vos Janet R, Hoogerbrugge Nicoline

机构信息

Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.

Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.

出版信息

Clin Genet. 2025 Oct;108(4):400-411. doi: 10.1111/cge.14759. Epub 2025 Apr 28.

DOI:10.1111/cge.14759
PMID:40289619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12405060/
Abstract

PTEN Hamartoma Tumor Syndrome (PHTS) is a rare hereditary syndrome. PHTS has a variable phenotype characterized by benign lesions and increased cancer risks. Clarifying the extent of the benign phenotype could facilitate early recognition of PHTS patients before cancer development. Therefore, we assessed the spectrum, frequency, and age of excerpt of pathology-confirmed benign lesions in PHTS patients. Pathology reports were collected for 379 patients with a pathogenic PTEN variant from the Dutch nationwide pathology databank (Palga). Benign lesions were classified as PHTS-related based on current clinical diagnostic guidelines and non-PHTS-related lesions by ICD-10 codes. Age of last follow-up was year of pathology request minus birth year. Analyses were stratified by sex and index status. Patients presented mainly with gastrointestinal (54%), skin (47%), thyroid (31%) and vascular lesions (26%). Males developed lipomas at an early age (9 years (5-34)). Females developed endometrial hyperplasia (16%) at an earlier age (41 years (35-49)) and uterine polyps (13%) more often than the general population. No significant differences were observed between sexes or index and non-index patients. The results are reflective of current diagnostic guidelines. Early-onset lipomas may be useful for early detection of PHTS patients. Additionally, uterine polyps should be considered for inclusion as a PHTS-related lesion.

摘要

PTEN错构瘤综合征(PHTS)是一种罕见的遗传性综合征。PHTS具有可变的表型,其特征为良性病变和癌症风险增加。明确良性表型的范围有助于在癌症发生前早期识别PHTS患者。因此,我们评估了PHTS患者经病理证实的良性病变的范围、频率和出现年龄。从荷兰全国病理数据库(Palga)收集了379例携带致病性PTEN变异的患者的病理报告。根据当前临床诊断指南,良性病变被分类为与PHTS相关,通过ICD - 10编码分类为非PHTS相关病变。最后一次随访年龄为病理申请年份减去出生年份。分析按性别和索引状态分层。患者主要表现为胃肠道病变(54%)、皮肤病变(47%)、甲状腺病变(31%)和血管病变(26%)。男性在早年(9岁(5 - 34岁))出现脂肪瘤。女性比普通人群更早(41岁(35 - 49岁))出现子宫内膜增生(16%)且更频繁出现子宫息肉(13%)。在性别之间以及索引患者和非索引患者之间未观察到显著差异。结果反映了当前的诊断指南。早发性脂肪瘤可能有助于早期发现PHTS患者。此外,子宫息肉应被考虑纳入与PHTS相关的病变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4d/12405060/1e212bae5a7a/CGE-108-400-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4d/12405060/b03977f00059/CGE-108-400-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4d/12405060/d90892b8a6e5/CGE-108-400-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4d/12405060/1e212bae5a7a/CGE-108-400-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4d/12405060/b03977f00059/CGE-108-400-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4d/12405060/d90892b8a6e5/CGE-108-400-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4d/12405060/1e212bae5a7a/CGE-108-400-g003.jpg

相似文献

1
Deep Phenotyping of Pathology-Confirmed Benign Lesions in PTEN Hamartoma Tumor Syndrome Patients.PTEN错构瘤综合征患者病理确诊良性病变的深度表型分析
Clin Genet. 2025 Oct;108(4):400-411. doi: 10.1111/cge.14759. Epub 2025 Apr 28.
2
Hamartoma Tumor Syndrome错构瘤综合征
3
Colonic manifestations of PTEN hamartoma tumor syndrome: case series and systematic review.PTEN错构瘤肿瘤综合征的结肠表现:病例系列及系统评价
World J Gastroenterol. 2014 Feb 21;20(7):1833-8. doi: 10.3748/wjg.v20.i7.1833.
4
Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria.考登综合征和 PTEN 错构瘤肿瘤综合征:系统评价和修订的诊断标准。
J Natl Cancer Inst. 2013 Nov 6;105(21):1607-16. doi: 10.1093/jnci/djt277. Epub 2013 Oct 17.
5
Non-serous ovarian cancer in PTEN Hamartoma Tumor Syndrome: additional evidence for increased risk.PTEN错构瘤综合征中的非浆液性卵巢癌:风险增加的更多证据。
Fam Cancer. 2025 Mar 18;24(2):28. doi: 10.1007/s10689-025-00453-z.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells.PTEN错构瘤肿瘤综合征患者的免疫失调:FOXP3调节性T细胞分析
J Allergy Clin Immunol. 2017 Feb;139(2):607-620.e15. doi: 10.1016/j.jaci.2016.03.059. Epub 2016 Jun 18.
8
Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome.内皮细胞中PTEN的体细胞单亲二倍体导致PTEN错构瘤肿瘤综合征患者出现血管畸形。
Cancer Discov. 2025 Jul 3;15(7):1350-1362. doi: 10.1158/2159-8290.CD-24-0807.
9
Histopathological phenotyping of cancers in PTEN Hamartoma Tumor Syndrome for improved recognition: A single-center study.PTEN 错构瘤综合征相关癌症的组织病理学表型分析以提高识别率:一项单中心研究。
Int J Cancer. 2024 Nov 1;155(9):1567-1576. doi: 10.1002/ijc.35049. Epub 2024 Jun 11.
10
PTEN hamartoma tumour syndrome: case report based on data from the Iranian hereditary colorectal cancer registry and literature review.PTEN 错构瘤肿瘤综合征:基于伊朗遗传性结直肠癌登记处数据和文献复习的病例报告。
Diagn Pathol. 2023 Apr 4;18(1):43. doi: 10.1186/s13000-023-01331-x.

本文引用的文献

1
Experience in a PTEN Hamartoma Tumor Syndrome Expertise Centre: Yield of Thyroid Ultrasound Surveillance in Children with PTEN Hamartoma Tumor Syndrome.PTEN错构瘤综合征专家中心的经验:PTEN错构瘤综合征患儿甲状腺超声监测的结果
J Clin Res Pediatr Endocrinol. 2025 Mar 19;17(1):46-57. doi: 10.4274/jcrpe.galenos.2024.2024-3-14. Epub 2024 Aug 8.
2
Histopathological phenotyping of cancers in PTEN Hamartoma Tumor Syndrome for improved recognition: A single-center study.PTEN 错构瘤综合征相关癌症的组织病理学表型分析以提高识别率:一项单中心研究。
Int J Cancer. 2024 Nov 1;155(9):1567-1576. doi: 10.1002/ijc.35049. Epub 2024 Jun 11.
3
Detection and yield of thyroid cancer surveillance in adults with PTEN hamartoma tumour syndrome.
PTEN 错构瘤肿瘤综合征成人患者的甲状腺癌监测的检出率和产量。
Endocr Relat Cancer. 2023 Aug 16;30(10). doi: 10.1530/ERC-23-0009. Print 2023 Oct 1.
4
Yield of annual endometrial cancer surveillance in women with PTEN Hamartoma Tumor Syndrome.PTEN 错构瘤肿瘤综合征女性的年度子宫内膜癌监测的检出率。
Eur J Med Genet. 2023 Jul;66(7):104785. doi: 10.1016/j.ejmg.2023.104785. Epub 2023 May 11.
5
The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor Syndrome.PTEN 错构瘤肿瘤综合征女性乳腺癌监测的产量和效果。
Cancer. 2022 Aug 1;128(15):2883-2891. doi: 10.1002/cncr.34326. Epub 2022 Jun 1.
6
Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort.大型PTEN错构瘤肿瘤综合征(PHTS)患者队列中的基因型-表型关联
Eur J Med Genet. 2022 Dec;65(12):104632. doi: 10.1016/j.ejmg.2022.104632. Epub 2022 Oct 18.
7
Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome.PTEN错构瘤肿瘤综合征中按性别和变异类型划分的癌症风险
J Natl Cancer Inst. 2023 Jan 10;115(1):93-103. doi: 10.1093/jnci/djac188.
8
Detection and Yield of Colorectal Cancer Surveillance in Adults with Hamartoma Tumour Syndrome.错构瘤综合征成年患者结直肠癌监测的检测与检出率
Cancers (Basel). 2022 Aug 19;14(16):4005. doi: 10.3390/cancers14164005.
9
Validation of a computational phenotype for finding patients eligible for genetic testing for pathogenic PTEN variants across three centers.验证一种计算表型,以在三个中心找到符合致病性 PTEN 变异基因检测条件的患者。
J Neurodev Disord. 2022 Mar 23;14(1):24. doi: 10.1186/s11689-022-09434-0.
10
Red flags for early recognition of adult patients with PTEN Hamartoma Tumour Syndrome.PTEN 错构瘤肿瘤综合征成年患者早期识别的危险信号。
Eur J Med Genet. 2021 Dec;64(12):104364. doi: 10.1016/j.ejmg.2021.104364. Epub 2021 Oct 9.